Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Faivre

Showing results (31-40 of 139) with videos related to

Pageof 14
Sort By:
Cancer Treatment Reviews|October 7, 2014
Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumorsJuan W Valle, Sandrine Faivre, Richard A Hubner, et al.
Targeted Oncology|August 23, 2012
New treatment options with cytotoxic agents in neuroendocrine tumoursPascal Hammel, Olivia Hentic, Cindy Neuzillet, et al.
Pharmacoeconomics|March 6, 2014
Methods for adjusting for bias due to crossover in oncology trialsK Jack Ishak, Irina Proskorovsky, Beata Korytowsky, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resectionSabine Irtan, Xavier Chopin-Laly, Maxime Ronot, et al.
Expert Opinion on Investigational Drugs|June 24, 2010
New inhibitors of the mammalian target of rapamycin signaling pathway for cancerSébastien Albert, Maria Serova, Chantal Dreyer, et al.
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed: novel associations and mechanisms of resistance]Marie-Paule Sablin, Christophe Le Tourneau, Ghassan El Maalouf, et al.
Cancer Metastasis Reviews|May 22, 2013
Stromal expression of SPARC in pancreatic adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, et al.
Cancer Treatment Reviews|November 26, 2008
Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancerGhassan El Maalouf, Christophe Le Tourneau, Georges Nicolas Batty, et al.
Pharmacology & Therapeutics|October 15, 2013
MEK in cancer and cancer therapyCindy Neuzillet, Annemilaï Tijeras-Raballand, Louis de Mestier, et al.
Oncotarget|July 13, 2015
Targeting cancer cell metabolism in pancreatic adenocarcinomaRomain Cohen, Cindy Neuzillet, Annemilaï Tijeras-Raballand, et al.
Pageof 14

Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
Cancer Treatment Reviews|October 7, 2014
Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumorsJuan W Valle, Sandrine Faivre, Richard A Hubner, et al.
Targeted Oncology|August 23, 2012
New treatment options with cytotoxic agents in neuroendocrine tumoursPascal Hammel, Olivia Hentic, Cindy Neuzillet, et al.
Pharmacoeconomics|March 6, 2014
Methods for adjusting for bias due to crossover in oncology trialsK Jack Ishak, Irina Proskorovsky, Beata Korytowsky, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resectionSabine Irtan, Xavier Chopin-Laly, Maxime Ronot, et al.
Expert Opinion on Investigational Drugs|June 24, 2010
New inhibitors of the mammalian target of rapamycin signaling pathway for cancerSébastien Albert, Maria Serova, Chantal Dreyer, et al.
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and pemetrexed: novel associations and mechanisms of resistance]Marie-Paule Sablin, Christophe Le Tourneau, Ghassan El Maalouf, et al.
Cancer Metastasis Reviews|May 22, 2013
Stromal expression of SPARC in pancreatic adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, et al.
Cancer Treatment Reviews|November 26, 2008
Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancerGhassan El Maalouf, Christophe Le Tourneau, Georges Nicolas Batty, et al.
Pharmacology & Therapeutics|October 15, 2013
MEK in cancer and cancer therapyCindy Neuzillet, Annemilaï Tijeras-Raballand, Louis de Mestier, et al.
Oncotarget|July 13, 2015
Targeting cancer cell metabolism in pancreatic adenocarcinomaRomain Cohen, Cindy Neuzillet, Annemilaï Tijeras-Raballand, et al.
Pageof 14